Daiwa Securities Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-115
| Closed | -$2K | – | 1420 |
|
|
2025
Q4 | $2K | Sell |
115
-100
| -47% | -$1.66K | ﹤0.01% | 1325 |
|
|
2025
Q3 | $3K | Hold |
215
| – | – | ﹤0.01% | 1251 |
|
|
2025
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1229 |
|
|
2025
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1198 |
|
|
2024
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1233 |
|
|
2024
Q3 | $2K | Buy |
215
+200
| +1,333% | +$1.73K | ﹤0.01% | 1234 |
|
|
2024
Q2 | $0 | Sell |
15
-200
| -93% | -$1.8K | ﹤0.01% | 1367 |
|
|
2024
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1282 |
|
|
2023
Q3 | $2K | Hold |
215
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1248 |
|
|
2023
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1227 |
|
|
2022
Q4 | $2K | Hold |
215
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q3 | $2K | Hold |
215
| – | – | ﹤0.01% | 1249 |
|
|
2022
Q2 | $2K | Hold |
215
| – | – | ﹤0.01% | 1256 |
|
|
2022
Q1 | $2K | Hold |
215
| – | – | ﹤0.01% | 1272 |
|
|
2021
Q4 | $2K | Buy |
215
+95
| +79% | +$828 | ﹤0.01% | 1300 |
|
|
2021
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 1285 |
|
|
2021
Q2 | $2K | Hold |
120
| – | – | ﹤0.01% | 1160 |
|
|
2021
Q1 | $2K | Hold |
120
| – | – | ﹤0.01% | 1164 |
|
|
2020
Q4 | $2K | Sell |
120
-228
| -66% | -$4.09K | ﹤0.01% | 1141 |
|
|
2020
Q3 | $5K | Hold |
348
| – | – | ﹤0.01% | 1096 |
|
|
2020
Q2 | $32K | Hold |
348
| – | – | ﹤0.01% | 978 |
|
|
2020
Q1 | $8K | Buy |
348
+28
| +9% | +$701 | ﹤0.01% | 1076 |
|
|
2019
Q4 | $7K | Sell |
320
-33
| -9% | -$641 | ﹤0.01% | 1089 |
|
|
2019
Q3 | $7K | Hold |
353
| – | – | ﹤0.01% | 1056 |
|
|
2019
Q2 | $6K | Hold |
353
| – | – | ﹤0.01% | 1084 |
|
|
2019
Q1 | $8K | Buy |
+353
| New | +$8.95K | ﹤0.01% | 1046 |
|
|
2018
Q4 | – | Sell |
-299
| Closed | -$10K | – | 1184 |
|
|
2018
Q3 | $10K | Hold |
299
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q2 | $7K | Hold |
299
| – | – | ﹤0.01% | 1075 |
|
|
2018
Q1 | $7K | Buy |
+299
| New | +$8.21K | ﹤0.01% | 1058 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
Daiwa Securities Group's TBPH Position: Q1 2026 in Review
Daiwa Securities Group sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 115 shares — an estimated $2K sold.
Daiwa Securities Group first reported a position in TBPH in Q1 2018 and held it in 31 quarters. The position peaked at $32K in Q2 2020. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.
- Daiwa Securities Group reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 115 Theravance Biopharma shares in Q1 2026, an estimated $2K.
- Daiwa Securities Group first reported a position in Theravance Biopharma in Q1 2018 and held it in 31 quarters.
- Daiwa Securities Group's Theravance Biopharma position peaked at $32K in Q2 2020.
- 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.